Sublingual Allergy Immunotherapy Market Expected To Achieve A Strong 14.24% CAGR, To Reach USD 3.5 Billion By 2032
Sublingual Allergy Immunotherapy Market The rising of allergic diseases, such as allergic rhinitis and asthma, is a factor driving the grow ...
Frontiers6h
Advances in Cow's Milk Allergy Management: Proteomics, Hypoallergenic Formulas, and Food Processing Innovations
Cow's milk allergy (CMA) management remains a complex challenge necessitating the avoidance of allergenic proteins and, often ...
Hosted on MSN22h
What Is Allergy Immunotherapy, and Does It Work?
Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...
news.ucsb.edu1d
‘Brave and bold’ new strategies for cancer immunotherapy
Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...
The Pharma Letter1d
First-in-class treatment approved by NICE for allergic rhinitis
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
National Health Executive1d
New allergy drug endorsed by NICE
NICE has endorsed a new daily tablet treatment, Acarizax, designed to alleviate symptoms and enhance the quality of life for ...
ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to ...
Dust mites 101: What they are and what to do about them
Dust mites are insect-like pests that live in mattresses, pillows and soft surfaces. We spoke with experts about how to get ...